Health and Me

Ishita Roy

Explained: An Overview Of How Vaccine Policies Have Changed Under RFK Jr

When RF Kennedy Jr took over HHS, he promised he would not “take away” Americans’ vaccines. In practice, though, his office has made a string of moves that reshape who is recommended to get which shots, who decides those recommendations, and where federal vaccine money goes. 

The changes so far include replacing the federal vaccine advisory panel, narrowing some <span>COVID vaccine</span> guidance, removing a flu preservative from recommendations, pulling funding for certain mRNA vaccine projects, and ordering new reviews of the childhood shot schedule. 

These moves matter because federal recommendations and HHS approvals strongly influence insurance coverage, which vaccines are stocked in clinics and pharmacies, and what doctors tell patients. 

<h4>New management: what happened to the advisory panel</h4>

One of Kennedy’s first major steps was to remove the existing members of the Advisory Committee on Immunization Practices, or ACIP. ACIP is the independent panel that for decades has advised the Centers for Disease Control (<span>CDC</span>) on who should get which vaccines and when.

<strong>READ: <a href="https://www.healthandme.com/health-news/top-u-s-medical-associations-ousted-from-cdc-vaccine-workgroups-in-sudden-shake-up-article-152394922" data-type="tilCustomLink">Top U.S. Medical Associations Ousted from CDC Vaccine Workgroups in Sudden Shake-Up</a></strong>

Kennedy dismissed the 17 sitting members and installed a much smaller, handpicked panel. He said the old committee had conflicts of interest and was not trusted by the public. 

Critics say the move breaks long-standing safeguards meant to keep scientific review independent and transparent. The change also shifted which outside experts are invited to brief the committee and who sits on the working groups that prepare the technical evidence.

<strong>READ MORE:<a href="https://www.healthandme.com/health-news/rfk-jr-overhauls-and-shakes-up-the-vaccine-advisory-panel-again-find-out-the-whos-who-on-this-new-team-article-152415486" data-type="tilCustomLink"> RFK Jr. Overhauls And Shakes-Up The Vaccine Advisory Panel Again, Find Out The Who’s Who On This New Team</a></strong> 

<h4>COVID-19 shots: who is recommended to get them now</h4>

Under Kennedy, federal guidance on COVID-19 vaccination has narrowed in key ways:

For healthy children and for people who are pregnant, the government removed the blanket “routine” recommendation and moved to a weaker status. 

HHS announced that healthy children and pregnant women are no longer on the routine immunization schedule, saying these groups should make decisions in discussion with their doctors.

<strong>READ: <a href="https://www.healthandme.com/health-news/rfk-jr-announces-cdc-no-longer-recommends-covid-vaccine-for-kids-and-pregnant-women-what-do-experts-think-article-151745014" data-type="tilCustomLink">CDC No Longer Recommends COVID Vaccine For Kids And Pregnant Women - What Do Experts Think?</a></strong>

That change was public and political, and it happened before ACIP had a formal vote. Medical groups such as the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics criticized the move and warned it would cause confusion. 

Separately, the Food and Drug Administration (FDA) has signaled that approval will be focused on older adults and people at high risk for severe disease. The FDA’s guidance narrows the groups for which updated COVID shots can be authorized unless vaccine makers run larger trials or meet new evidence requirements. That means many healthy adults and children may not be covered or prioritized for the updated shots unless ACIP or HHS changes course later.

<strong>READ MORE: <a href="https://www.healthandme.com/health-news/new-covid-19-vaccine-policies-are-already-blocking-people-from-getting-shotswho-is-at-real-risk-article-152076301" data-type="tilCustomLink">New Covid-19 Vaccine Policies Are Already Blocking People From Getting Shots—Who Is At Real Risk?</a></strong>

Why this matters: when the CDC labels a vaccine as “recommended,” insurance plans and public programs usually pay for it. Removing routine recommendations or narrowing approvals can make shots harder or more expensive to get, and can change what pharmacies and health centers stock. That creates practical barriers for people who might otherwise want or need protection. 

<h4>Flu shots and thimerosal: a controversial preservative ban</h4>

At an ACIP meeting under Kennedy’s new appointees, the committee voted to recommend that seasonal influenza vaccines used in the U.S. be free of the preservative thimerosal.

<strong>READ: <a href="https://www.healthandme.com/health-news/rfk-jr-orders-thimerosal-removed-from-all-us-flu-shots-article-152334591" data-type="tilCustomLink">RFK Jr. Orders Thimerosal Removed From All US Flu Shots</a></strong>

Thimerosal contains ethylmercury and has long been a focus of concern among vaccine skeptics even though public health agencies have found no credible evidence that it causes autism or long-term harm at the tiny amounts historically used in multi-dose vials. 

In the United States most flu doses are already supplied in single-dose syringes that do not contain thimerosal, but some clinics and global programs still use multi-dose vials because they are cheaper and easier to ship. Removing thimerosal from U.S. recommendations could raise costs and complicate access for settings that rely on multi-dose vials, like some rural clinics and international programs.

<strong>READ MORE: <a href="https://www.healthandme.com/health-news/former-anti-vaccine-leader-to-weigh-in-on-cdc-vaccine-strategy-article-152140081" data-type="tilCustomLink">Former Anti-Vaccine Leader to Weigh In On CDC Vaccine Strategy</a></strong>

What the agencies said: HHS and the new ACIP members framed the choice as restoring public trust and eliminating a preservative that activists have long criticized. Critics point out that the science does not support that thimerosal at vaccine doses causes harm, and they worry removing it will reduce vaccine availability or increase price without improving safety. 

<h4>Respiratory syncytial virus, or RSV: more access for some ages, new options for infants</h4>

Two big RSV moves happened during this period:

For infants, the CDC advisory group recommended a second long-acting monoclonal antibody product, clesrovimab (brand name Enflonsia), to prevent severe RSV disease in babies under eight months who are not protected by maternal vaccination.

<strong>READ: <a href="https://www.healthandme.com/health-news/new-recommendations-made-on-rsv-meningitis-and-chikungunya-vaccines-article-151439504" data-type="tilCustomLink">New Recommendations Made On RSV, Meningitis, And Chikungunya Vaccines</a></strong>

The FDA had already approved the product and ACIP voted to include it so it can be used and covered for infants entering their first RSV season. Having a second product helps guard against shortages and can lower costs over time. 

For older adults, ACIP recommendations were expanded so that adults in their 50s with high-risk conditions can receive an RSV vaccine. Kennedy signed off on accepting the advisory committee’s recommendation for that broader high-risk group. That change means people in their 50s with specific health problems may now be eligible for RSV shots. 

One of the most notable policy shifts is the new panel’s decision to examine the cumulative health effects of the entire childhood immunization schedule. That means ACIP will look again at the timing and combination of routine childhood vaccines that, for decades, have been recommended to protect children against measles, polio, pertussis, hepatitis B, and many other diseases. The committee also signaled possible re-examination of specific items such as the birth dose of hepatitis B and the combined MMRV vaccine that mixes measles, mumps, rubella and varicella. 

Supporters of the review say it is a reasonable recheck. Critics say the review is driven by unfounded concerns and risks undermining long-standing, evidence-based prevention.

<strong>READ: <a href="https://www.healthandme.com/health-news/fda-approves-new-covid-vaccine-for-kids-with-selective-eligibility-article-152262209" data-type="tilCustomLink">FDA Approves New Covid Vaccine For Kids With Selective Eligibility</a></strong>

Why people are worried: federal recommendations guide school vaccine rules, insurance coverage, and what pediatricians routinely offer. Even talk about changing the schedule or re-opening decisions that were closed decades ago can trigger parents’ doubts and lead to lower vaccination rates. That is especially concerning during a resurgent measles outbreak in parts of the country. Public health groups and pediatricians have pushed back strongly. 

<h4>HPV, MMRV, Hepatitis B and other specific vaccines</h4>

Several single-vaccine items that were moving through the advisory pipeline have been delayed or placed under further review:

<strong>HPV: </strong>A planned vote that would have moved the routine recommendation window earlier, to routinely recommend vaccination starting at age 9 instead of 11, was removed from the agenda. That delay left clinicians and program planners uncertain about the future of younger-age recommendations. Kennedy has prior legal involvement in litigation related to the HPV vaccine that adds context to the committee’s caution.

<strong>READ: <a href="https://www.healthandme.com/health-wellness/who-needs-hpv-vaccine-guide-for-every-parent-teen-and-adult-article-151318524" data-type="tilCustomLink">Who Needs HPV Vaccine? Guide For Every Parent, Teen And Adult</a></strong> 

<strong>MMRV (the combined measles-mumps-rubella-varicella shot): </strong>the new panel signaled it would weigh the risks and benefits of the combination vaccine, in part because of data on rare febrile seizures in very young children. Pediatricians say the increased seizure risk is small and generally benign, but the panel’s attention to the issue has stirred fresh debate.

<strong>READ: <a href="https://www.healthandme.com/health-news/amid-measles-outbreak-texas-makes-vaccine-exemption-easier-for-kids-article-151735741" data-type="tilCustomLink">Amid Measles Outbreak, Texas Makes Vaccine Exemption Easier For Kids</a></strong> 

Hepatitis B at birth: ACIP said it will review whether the birth dose for infants should remain routine when the mother tests negative. The American Academy of Pediatrics strongly defends the birth dose because it prevents lifelong hepatitis B infections. The review has alarmed many clinicians who see no credible evidence that newborns are at low enough risk to change the practice.

<strong>READ: <a href="https://www.healthandme.com/health-wellness/can-a-quick-visit-to-a-salon-increase-your-risk-of-hepatitis-b-article-152023173" data-type="tilCustomLink">Can A Quick Visit To A Salon Increase Your Risk Of Hepatitis B?</a></strong>

<h4>Money and research: mRNA funding pulled or reshaped</h4>

HHS under Kennedy announced a large shift in federal investments tied to mRNA vaccine development. The department moved to wind down or restructure a set of BARDA and other contracts that supported mRNA vaccine projects, including high-profile programs aimed at pre-pandemic influenza and other threats. The cited reason was concern about the platform’s effectiveness for upper respiratory infections and a stated desire to invest in what the department calls “broader” or alternative vaccine technologies. Scientists warn that pulling this money risks hampering rapid-response vaccine capacity in future outbreaks. Industry groups and researchers have pushed back, noting that mRNA technology enabled the rapid COVID-19 response and remains a major tool for future pandemics.

<strong>READ:<a href="https://www.healthandme.com/health-news/rfk-jr-pulls-500-million-funds-from-mrna-vaccine-projects-says-the-focus-will-be-shifted-to-traditional-vaccines-article-152416445" data-type="tilCustomLink"> RFK Jr Pulls 500 Million Funds From mRNA Vaccine Projects, Says The Focus Will Be Shifted To 'Traditional' Vaccines</a></strong> 

<h4>Legal fights, professional pushback, and the practical fallout</h4>

Several national medical organizations and public health groups have publicly protested or taken legal steps to challenge Kennedy’s changes. In July a coalition led by the American Academy of Pediatrics, along with other large medical societies and public health organizations, filed a lawsuit seeking to reverse the HHS directive that removed COVID-19 vaccines for healthy children and pregnant women from routine recommendations. Other associations were removed from vaccine workgroups, which has raised concerns about sidelining established expert voices. Meanwhile, some pharmacies and clinics began to report confusion about whether to offer COVID shots to pregnant women or healthy kids, and whether insurers would cover them. 

<h4>Who keeps easy access, who might lose it, and what to watch</h4>

Right now access looks most secure for people the new guidance and approvals clearly protect: older adults and people with underlying health conditions are largely still being recommended for key vaccines like COVID boosters and RSV shots. For healthy children and some healthy adults, access has become more uncertain because of narrower recommendations and the potential insurance implications.

Health Conditions A-Z

health

RFK jr

COVID 19

health and wellness

us health

health us

vaccine policies

RFK Jr vaccine policies

HHS RFK Jr

COVID VAccine

US Schools Reopen: Here Is Your Guide To The Lifesaving Vaccines Every Child Should Have

FDA Approves First Neuroimmune Modulation Device for Rheumatoid Arthritis

Health & Wellness

Stress Vs. Anxiety: Difference Explained In 60 seconds

Can You Get Heatstroke In Monsoon?

You’re Not Lazy! Women Do Need More Sleep Than Men

How To Ditch Daytime Sleepiness In Office?

Common Mistakes People Make While Eating Flaxseeds

Toddlers In India Are Missing Development Milestones: Study

Yoga Poses You Should Do For Back Pain

Healthy Brunch Ideas For A Lazy Weekend Meal

Balancing Exercises You Should Do For Stability

How Much Can Food Affect Menstruation?

What Should Fitness Look Like For A 13-18 Year Old

Food For Diabetes: What Should A Diabetic Diet Contain

You Don’t Always Need Weights For Strength Training

Feel Sleepy After Lunches - Light And Healthy Office Lunches

Positive Thinking Practice – How Does It Help You?

MIND Diet – Is This A Healthy Diet Or Another Trend?

Yoga Prop Essentials To Improve Your Exercise Session

Should Potatoes Be The Part Of A Healthy Diet?

Best And Worst Foods To Lower Blood Pressure

Low-Impact Cardio Workouts You Should Try

10 Healthy Pasta Salad Dressing For Weight Loss

Breathing Exercise You Should Do To Relieve Stress

Headache vs. Migraine: Difference Explained In 60 Seconds

High Carb Foods That Are Actually Healthy

How Many Times Do You Need To Wash Your Face?

Hypothyroidism Diet – What To Eat And What You Should Avoid

Stretches To Relieve Leg Pain And Numbness After Sitting For Too Long

No-Cook Healthy Meals For Lazy Days At Home

Easy Breakfast Options To Try During Calorie Deficit

How To Stop Muscle Cramps Immediately

Why You Should Go For An Anti-Inflammatory Diet

Foods To Lower Cortisol Levels In Your Body

High-Fiber Dips You Can Make At Home For The Week

Weekend Warrior Exercises To Makeup For Stressful Week

Experiencing Headaches At Word? Natural Remedies To Try

Yoga Poses That Enhance Digestion

Health Benefits of Walking Backwards

No Eggs? Egg-Alternatives You Can Add To Your Diet

Savory And Smart Ways To Add Broccoli To Your Diet

Calorie Burning Habits That Can Help You Shed Extra Pounds

When RF Kennedy Jr took over HHS, he promised he would not “take away” Americans’ vaccines. In practice, though, his office has made a string of moves that reshape who is recommended to get which shots, who decides those recommendations, and where federal vaccine money goes. The changes so far include replacing the federal vaccine advisory panel, narrowing some COVID vaccine guidance, removing a flu preservative from recommendations, pulling funding for certain mRNA vaccine projects, and ordering new reviews of the childhood shot schedule. These moves matter because federal recommendations and HHS approvals strongly influence insurance coverage, which vaccines are stocked in clinics and pharmacies, and what doctors tell patients. New management: what happened to the advisory panelOne of Kennedy’s first major steps was to remove the existing members of the Advisory Committee on Immunization Practices, or ACIP. ACIP is the independent panel that for decades has advised the Centers for Disease Control (CDC) on who should get which vaccines and when.READ: Top U.S. Medical Associations Ousted from CDC Vaccine Workgroups in Sudden Shake-UpKennedy dismissed the 17 sitting members and installed a much smaller, handpicked panel. He said the old committee had conflicts of interest and was not trusted by the public. Critics say the move breaks long-standing safeguards meant to keep scientific review independent and transparent. The change also shifted which outside experts are invited to brief the committee and who sits on the working groups that prepare the technical evidence.READ MORE: RFK Jr. Overhauls And Shakes-Up The Vaccine Advisory Panel Again, Find Out The Who’s Who On This New Team COVID-19 shots: who is recommended to get them nowUnder Kennedy, federal guidance on COVID-19 vaccination has narrowed in key ways:For healthy children and for people who are pregnant, the government removed the blanket “routine” recommendation and moved to a weaker status. HHS announced that healthy children and pregnant women are no longer on the routine immunization schedule, saying these groups should make decisions in discussion with their doctors.READ: CDC No Longer Recommends COVID Vaccine For Kids And Pregnant Women - What Do Experts Think?That change was public and political, and it happened before ACIP had a formal vote. Medical groups such as the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics criticized the move and warned it would cause confusion. Separately, the Food and Drug Administration (FDA) has signaled that approval will be focused on older adults and people at high risk for severe disease. The FDA’s guidance narrows the groups for which updated COVID shots can be authorized unless vaccine makers run larger trials or meet new evidence requirements. That means many healthy adults and children may not be covered or prioritized for the updated shots unless ACIP or HHS changes course later.READ MORE: New Covid-19 Vaccine Policies Are Already Blocking People From Getting Shots—Who Is At Real Risk?Why this matters: when the CDC labels a vaccine as “recommended,” insurance plans and public programs usually pay for it. Removing routine recommendations or narrowing approvals can make shots harder or more expensive to get, and can change what pharmacies and health centers stock. That creates practical barriers for people who might otherwise want or need protection. Flu shots and thimerosal: a controversial preservative banAt an ACIP meeting under Kennedy’s new appointees, the committee voted to recommend that seasonal influenza vaccines used in the U.S. be free of the preservative thimerosal.READ: RFK Jr. Orders Thimerosal Removed From All US Flu ShotsHHS adopted that recommendation. Thimerosal contains ethylmercury and has long been a focus of concern among vaccine skeptics even though public health agencies have found no credible evidence that it causes autism or long-term harm at the tiny amounts historically used in multi-dose vials. In the United States most flu doses are already supplied in single-dose syringes that do not contain thimerosal, but some clinics and global programs still use multi-dose vials because they are cheaper and easier to ship. Removing thimerosal from U.S. recommendations could raise costs and complicate access for settings that rely on multi-dose vials, like some rural clinics and international programs.READ MORE: Former Anti-Vaccine Leader to Weigh In On CDC Vaccine StrategyWhat the agencies said: HHS and the new ACIP members framed the choice as restoring public trust and eliminating a preservative that activists have long criticized. Critics point out that the science does not support that thimerosal at vaccine doses causes harm, and they worry removing it will reduce vaccine availability or increase price without improving safety. Respiratory syncytial virus, or RSV: more access for some ages, new options for infantsTwo big RSV moves happened during this period:For infants, the CDC advisory group recommended a second long-acting monoclonal antibody product, clesrovimab (brand name Enflonsia), to prevent severe RSV disease in babies under eight months who are not protected by maternal vaccination.READ: New Recommendations Made On RSV, Meningitis, And Chikungunya VaccinesThe FDA had already approved the product and ACIP voted to include it so it can be used and covered for infants entering their first RSV season. Having a second product helps guard against shortages and can lower costs over time. For older adults, ACIP recommendations were expanded so that adults in their 50s with high-risk conditions can receive an RSV vaccine. Kennedy signed off on accepting the advisory committee’s recommendation for that broader high-risk group. That change means people in their 50s with specific health problems may now be eligible for RSV shots. Childhood schedule reviewOne of the most notable policy shifts is the new panel’s decision to examine the cumulative health effects of the entire childhood immunization schedule. That means ACIP will look again at the timing and combination of routine childhood vaccines that, for decades, have been recommended to protect children against measles, polio, pertussis, hepatitis B, and many other diseases. The committee also signaled possible re-examination of specific items such as the birth dose of hepatitis B and the combined MMRV vaccine that mixes measles, mumps, rubella and varicella. Supporters of the review say it is a reasonable recheck. Critics say the review is driven by unfounded concerns and risks undermining long-standing, evidence-based prevention.READ: FDA Approves New Covid Vaccine For Kids With Selective EligibilityWhy people are worried: federal recommendations guide school vaccine rules, insurance coverage, and what pediatricians routinely offer. Even talk about changing the schedule or re-opening decisions that were closed decades ago can trigger parents’ doubts and lead to lower vaccination rates. That is especially concerning during a resurgent measles outbreak in parts of the country. Public health groups and pediatricians have pushed back strongly. HPV, MMRV, Hepatitis B and other specific vaccinesSeveral single-vaccine items that were moving through the advisory pipeline have been delayed or placed under further review:HPV: A planned vote that would have moved the routine recommendation window earlier, to routinely recommend vaccination starting at age 9 instead of 11, was removed from the agenda. That delay left clinicians and program planners uncertain about the future of younger-age recommendations. Kennedy has prior legal involvement in litigation related to the HPV vaccine that adds context to the committee’s caution.READ: Who Needs HPV Vaccine? Guide For Every Parent, Teen And Adult MMRV (the combined measles-mumps-rubella-varicella shot): the new panel signaled it would weigh the risks and benefits of the combination vaccine, in part because of data on rare febrile seizures in very young children. Pediatricians say the increased seizure risk is small and generally benign, but the panel’s attention to the issue has stirred fresh debate.READ: Amid Measles Outbreak, Texas Makes Vaccine Exemption Easier For Kids Hepatitis B at birth: ACIP said it will review whether the birth dose for infants should remain routine when the mother tests negative. The American Academy of Pediatrics strongly defends the birth dose because it prevents lifelong hepatitis B infections. The review has alarmed many clinicians who see no credible evidence that newborns are at low enough risk to change the practice.READ: Can A Quick Visit To A Salon Increase Your Risk Of Hepatitis B?Money and research: mRNA funding pulled or reshapedHHS under Kennedy announced a large shift in federal investments tied to mRNA vaccine development. The department moved to wind down or restructure a set of BARDA and other contracts that supported mRNA vaccine projects, including high-profile programs aimed at pre-pandemic influenza and other threats. The cited reason was concern about the platform’s effectiveness for upper respiratory infections and a stated desire to invest in what the department calls “broader” or alternative vaccine technologies. Scientists warn that pulling this money risks hampering rapid-response vaccine capacity in future outbreaks. Industry groups and researchers have pushed back, noting that mRNA technology enabled the rapid COVID-19 response and remains a major tool for future pandemics.READ: RFK Jr Pulls 500 Million Funds From mRNA Vaccine Projects, Says The Focus Will Be Shifted To 'Traditional' Vaccines Legal fights, professional pushback, and the practical falloutSeveral national medical organizations and public health groups have publicly protested or taken legal steps to challenge Kennedy’s changes. In July a coalition led by the American Academy of Pediatrics, along with other large medical societies and public health organizations, filed a lawsuit seeking to reverse the HHS directive that removed COVID-19 vaccines for healthy children and pregnant women from routine recommendations. Other associations were removed from vaccine workgroups, which has raised concerns about sidelining established expert voices. Meanwhile, some pharmacies and clinics began to report confusion about whether to offer COVID shots to pregnant women or healthy kids, and whether insurers would cover them. Who keeps easy access, who might lose it, and what to watchRight now access looks most secure for people the new guidance and approvals clearly protect: older adults and people with underlying health conditions are largely still being recommended for key vaccines like COVID boosters and RSV shots. For healthy children and some healthy adults, access has become more uncertain because of narrower recommendations and the potential insurance implications.

explained: an overview of how vaccine policies have changed under rfk jr

Supriya Ramesh

Credits: Canva

Health News

The mRNA Vaccine Beat COVID And Could Cure Cancer—So Why Has RFK Jr Defunded It?

the mrna vaccine beat covid and could cure cancer—so why has rfk jr defunded it?

RFK Jr Pulls 500 Million Funds From mRNA Vaccine Projects, Says The Focus Will Be Shifted To 'Traditional' Vaccines

rfk jr pulls $500 million funds from mrna vaccine projects, says the focus will be shifted to 'traditional' vaccines

Mosquitoes Deployed To Kill Virus-Carrying Mosquito Larvae: How China Is Using Biological Weapons To Wage War Against Chikungunya

mosquitoes deployed to kill virus-carrying mosquito larvae: how china is using biological weapons to wage war against chikungunya

<span>National Immunisation Awareness Month</span>: Alongside the excitement of meeting new teachers and friends, the start of the US school year will also bring runny noses, hacking coughs, and bugs that somehow make their way through the entire classroom in a week. If you are sick, it is important to stay home. With a lot of people touching the same thing and germs everywhere, it is just important to watch your child's health and make sure to not spread it to other people.

Of course, handwashing, covering coughs and sneezes with a tissue or elbow, avoiding close contact with sick people, and regularly disinfecting frequently touched surfaces like doorknobs and de the first and necessary steps of everyday disease prevention. But there is another powerful shield that should not be ignored at any cost: <span>vaccines</span>.

Vaccines are not just for babies. They are a long-term health investment that keeps everything from the common flu to life-threatening infections at bay. Vaccines work; they help prevent diseases, and they help prevent infections. When enough people in a community are vaccinated, it creates <span>herd immunity</span>, meaning even those who cannot be vaccinated (due to medical reasons) get indirect protection. 

Yes, there are conversations and concerns around vaccines, but the best way to clear the air is to get accurate, up-to-date information from trusted sources. 

<strong>Here is <span rel="noindex">Centres for Disease Control and Prevention</span> (CDC) age-by-age vaccine cheat sheet</strong>

<ul><li>At birth: The journey starts right away with the first dose of the <span rel="noindex">Hepatitis B</span> (HepB) vaccine, which protects against a serious liver infection.</li><li>At 2 months: It is a busy month for tiny humans. They get doses of <span rel="noindex">DTaP</span> (Diphtheria, tetanus, and Pertussis), Hib (Haemophilus influenzae type b), IPV (<span rel="noindex">Polio</span>), PCV (Pneumococcal), and RV (<span rel="noindex">Rotavirus</span>).</li><li>4 months: Time for round two of the same five vaccines, because immunity is built gradually. </li><li>6 months: Another wave of protection with more DTaP, Hib, IPV (if needed), PCV, and RV doses. This is also when flu vaccines can be taken, and they will be recommended annually thereafter.</li><li>12–15 months: A milestone moment! Toddlers get the MMR (Measles, Mumps, Rubella), Varicella (<span rel="noindex">Chickenpox</span>), and HepA (Hepatitis A) vaccines. Some of the earlier series, like Hib and PCV, are also completed here.</li><li>15–18 months: The final DTaP dose in this stage rounds out protection against those three bacterial infections.</li><li>4–6 years: The finale before they head deeper into the school years; boosters for DTaP, IPV, MMR, and Varicella to ensure immunity stays strong.</li></ul>

<h3>Why this timing matters</h3>Spacing out vaccines is not about convenience; it is about giving the immune system the right cues at the right time. Too early, and the body might not respond effectively; too late, and there is a risk window where the child is vulnerable. That is why following the schedule is important. 

Vaccines do not just protect your child; they protect your child’s classmates, teachers, grandparents, and the stranger next to them. With schools reopening, the mix of close contact, shared surfaces, and high-energy kids is a perfect chance for germs to hop from one host to another. 

Vaccines are not about fear; they are about freedom. Freedom from the diseases that once claimed far too many young lives. They work quietly so your kids can focus on learning their ABCs, art, and running the school playground without worry. It is time to take a moment to check that your child’s vaccine schedule is up to date. 

vaccines

US Schools Reopen

herd immunity

Centres for Disease Control and Prevention

Hepatitis B

DTaP

polio

rotavirus

Chickenpox

National Immunisation Awareness Month

National Immunisation Awareness Month: Alongside the excitement of meeting new teachers and friends, the start of the US school year will also bring runny noses, hacking coughs, and bugs that somehow make their way through the entire classroom in a week. If you are sick, it is important to stay home. With a lot of people touching the same thing and germs everywhere, it is just important to watch your child's health and make sure to not spread it to other people.Of course, handwashing, covering coughs and sneezes with a tissue or elbow, avoiding close contact with sick people, and regularly disinfecting frequently touched surfaces like doorknobs and de the first and necessary steps of everyday disease prevention. But there is another powerful shield that should not be ignored at any cost: vaccines.Vaccines are not just for babies. They are a long-term health investment that keeps everything from the common flu to life-threatening infections at bay. Vaccines work; they help prevent diseases, and they help prevent infections. When enough people in a community are vaccinated, it creates herd immunity, meaning even those who cannot be vaccinated (due to medical reasons) get indirect protection. Yes, there are conversations and concerns around vaccines, but the best way to clear the air is to get accurate, up-to-date information from trusted sources. Here is Centres for Disease Control and Prevention (CDC) age-by-age vaccine cheat sheetAt birth: The journey starts right away with the first dose of the Hepatitis B (HepB) vaccine, which protects against a serious liver infection.At 2 months: It is a busy month for tiny humans. They get doses of DTaP (Diphtheria, tetanus, and Pertussis), Hib (Haemophilus influenzae type b), IPV (Polio), PCV (Pneumococcal), and RV (Rotavirus).4 months: Time for round two of the same five vaccines, because immunity is built gradually. 6 months: Another wave of protection with more DTaP, Hib, IPV (if needed), PCV, and RV doses. This is also when flu vaccines can be taken, and they will be recommended annually thereafter.12–15 months: A milestone moment! Toddlers get the MMR (Measles, Mumps, Rubella), Varicella (Chickenpox), and HepA (Hepatitis A) vaccines. Some of the earlier series, like Hib and PCV, are also completed here.15–18 months: The final DTaP dose in this stage rounds out protection against those three bacterial infections.4–6 years: The finale before they head deeper into the school years; boosters for DTaP, IPV, MMR, and Varicella to ensure immunity stays strong.Why this timing mattersSpacing out vaccines is not about convenience; it is about giving the immune system the right cues at the right time. Too early, and the body might not respond effectively; too late, and there is a risk window where the child is vulnerable. That is why following the schedule is important. What do vaccines do?Vaccines do not just protect your child; they protect your child’s classmates, teachers, grandparents, and the stranger next to them. With schools reopening, the mix of close contact, shared surfaces, and high-energy kids is a perfect chance for germs to hop from one host to another. Vaccines are not about fear; they are about freedom. Freedom from the diseases that once claimed far too many young lives. They work quietly so your kids can focus on learning their ABCs, art, and running the school playground without worry. It is time to take a moment to check that your child’s vaccine schedule is up to date. 

us schools reopen: here is your guide to the lifesaving vaccines every child should have

No More BBL For Non-Medics, UK to Regulate High-Risk Beauty Procedures

Nutrition

Fact Check: Is Kratom Supplement A 'Natural' Healer Or An 'Addictive' Danger?

fact check: is kratom supplement a 'natural' healer or an 'addictive' danger?

Eli Lilly’s New Weight Loss Pill Helped People With Obesity Shed Nearly 15% In Late-Stage Trials

eli lilly’s new weight loss pill helped people with obesity shed nearly 15% in late-stage trials

Could Lithium Deficiency In The Brain Trigger Alzheimer’s?

could lithium deficiency in the brain trigger alzheimer’s?

The UK government is taking firm action against unsafe and unregulated cosmetic procedures by introducing new legislation aimed at cleaning up what has been described as a “wild west” industry. Health Secretary Wes Streeting has announced that only qualified professionals will be allowed to carry out high-risk aesthetic treatments, including liquid <span>Brazilian butt lifts</span> (BBLs), under new rules expected next year.

<h4>Tighter Rules to Protect Patients</h4>

At present, no license is required to perform procedures like Botox injections or dermal fillers in England. This lack of oversight has led to a rise in botched treatments, some of which have caused permanent scarring, serious health complications, and even death. The government now plans to limit high-risk treatments to qualified healthcare professionals and require providers to be regulated by the Care Quality Commission (CQC).

Lower-risk cosmetic treatments, such as standard Botox and fillers, will also be subject to new licensing rules. Clinics offering these services must register with their local authority, ensuring they meet minimum safety and hygiene standards.

Liquid Brazilian butt lifts involve injecting filler into the buttocks to enhance their shape and size. While marketed as a less invasive alternative to surgical BBLs, the procedure comes with serious risks. These include the possibility of blood clots, infections like sepsis, and in rare cases, death.

In one tragic incident, a 33-year-old woman named Alice Webb died in Gloucestershire last year due to complications linked to a suspected liquid <span>BBL</span> procedure. Cases like hers have raised urgent questions about who is allowed to perform such high-risk treatments.

<h4>Crackdown on Unqualified Providers</h4>

Health officials are also investigating reports that treatments including BBLs, fat injections, and Botox are being offered by unqualified individuals in unregulated settings such as public toilets. The Chartered Trading Standards Institute recently issued a warning about these unsafe practices. Several people reported adverse reactions to Botox-like injections earlier this year, prompting further investigations.

To tackle this, the government is encouraging the public to verify providers’ qualifications and insurance, and to avoid unusually cheap offers that could signal unsafe practices.

The proposed changes will be introduced through amendments to the CQC’s regulations and secondary legislation. In addition to restricting who can offer these treatments, the government also plans to limit access to high-risk cosmetic procedures for under-18s unless they are approved by a qualified healthcare provider. England already made it illegal in 2021 for minors to receive Botox or dermal fillers.

Scotland has also announced similar regulatory plans, while Wales and Northern Ireland have yet to make any moves.

<h4>Support From Experts and Industry Leaders</h4>

Tim Mitchell, president of the Royal College of Surgeons, welcomed the move but called for stronger safeguards. He believes procedures like buttock or breast augmentation should only be carried out by board-recognised cosmetic surgeons. This, he said, would improve standards of care and reduce preventable harm.

Sue Davies of the consumer group Which? warned that these new rules would not be effective unless local enforcement teams, such as trading standards, are given more resources to act against rogue providers.

Millie Kendall, chief executive of the British Beauty Council, said the changes would restore public trust and reduce the number of horror stories associated with the beauty industry.

Health minister Karin Smyth said the government’s actions are aimed at protecting individuals from being exploited by untrained or dishonest practitioners. She emphasized that people will still be free to choose cosmetic treatments, but in a safer and more regulated environment. The goal is to provide peace of mind for consumers while easing the burden on the NHS, which often deals with the consequences of botched procedures.

brazilian butt lifts

BBL license

no more brazilian butt lifts

skincare

skin health

plastic surgery

The UK government is taking firm action against unsafe and unregulated cosmetic procedures by introducing new legislation aimed at cleaning up what has been described as a “wild west” industry. Health Secretary Wes Streeting has announced that only qualified professionals will be allowed to carry out high-risk aesthetic treatments, including liquid Brazilian butt lifts (BBLs), under new rules expected next year.Tighter Rules to Protect PatientsAt present, no license is required to perform procedures like Botox injections or dermal fillers in England. This lack of oversight has led to a rise in botched treatments, some of which have caused permanent scarring, serious health complications, and even death. The government now plans to limit high-risk treatments to qualified healthcare professionals and require providers to be regulated by the Care Quality Commission (CQC).Lower-risk cosmetic treatments, such as standard Botox and fillers, will also be subject to new licensing rules. Clinics offering these services must register with their local authority, ensuring they meet minimum safety and hygiene standards.Why Liquid BBLs Are a ConcernLiquid Brazilian butt lifts involve injecting filler into the buttocks to enhance their shape and size. While marketed as a less invasive alternative to surgical BBLs, the procedure comes with serious risks. These include the possibility of blood clots, infections like sepsis, and in rare cases, death.In one tragic incident, a 33-year-old woman named Alice Webb died in Gloucestershire last year due to complications linked to a suspected liquid BBL procedure. Cases like hers have raised urgent questions about who is allowed to perform such high-risk treatments.Crackdown on Unqualified ProvidersHealth officials are also investigating reports that treatments including BBLs, fat injections, and Botox are being offered by unqualified individuals in unregulated settings such as public toilets. The Chartered Trading Standards Institute recently issued a warning about these unsafe practices. Several people reported adverse reactions to Botox-like injections earlier this year, prompting further investigations.To tackle this, the government is encouraging the public to verify providers’ qualifications and insurance, and to avoid unusually cheap offers that could signal unsafe practices.Planned Legislative ChangesThe proposed changes will be introduced through amendments to the CQC’s regulations and secondary legislation. In addition to restricting who can offer these treatments, the government also plans to limit access to high-risk cosmetic procedures for under-18s unless they are approved by a qualified healthcare provider. England already made it illegal in 2021 for minors to receive Botox or dermal fillers.Scotland has also announced similar regulatory plans, while Wales and Northern Ireland have yet to make any moves.Support From Experts and Industry LeadersTim Mitchell, president of the Royal College of Surgeons, welcomed the move but called for stronger safeguards. He believes procedures like buttock or breast augmentation should only be carried out by board-recognised cosmetic surgeons. This, he said, would improve standards of care and reduce preventable harm.Sue Davies of the consumer group Which? warned that these new rules would not be effective unless local enforcement teams, such as trading standards, are given more resources to act against rogue providers.Millie Kendall, chief executive of the British Beauty Council, said the changes would restore public trust and reduce the number of horror stories associated with the beauty industry.A Step Towards Safer PracticesHealth minister Karin Smyth said the government’s actions are aimed at protecting individuals from being exploited by untrained or dishonest practitioners. She emphasized that people will still be free to choose cosmetic treatments, but in a safer and more regulated environment. The goal is to provide peace of mind for consumers while easing the burden on the NHS, which often deals with the consequences of botched procedures.

no more bbl for non-medics, uk to regulate high-risk beauty procedures

Tanya Dutt

Subtle Symptoms May Indicate To Early Warning Signs MS, 15 Years Before You Are Diagnosed

Oxford Study Reveals 6 Common Health Conditions That Could Lead To Dementia

oxford study reveals 6 common health conditions that could lead to dementia

Have You Ever Felt Dizzy, Lightheaded When You Stand Up? Here's What It Means

have you ever felt dizzy, lightheaded when you stand up? here's what it means

As China Revives COVID-Era Measures To Beat Chikungunya Virus, Here's All You Should Know About This Mosquito-borne Disease

as china revives covid-era measures to beat chikungunya virus, here's all you should know about this mosquito-borne disease

<span>Multiple sclerosis</span> (MS) tends to be viewed as an abrupt disease—vision loss, numbness, tiredness, and other neurological interruptions. But based on a revolutionary new study at the University of British Columbia (UBC), the body could begin to send warning signals as much as 15 years before a diagnosis is officially made.

This study, which appeared in JAMA Network Open, contradicts decades of premises on when MS really gets started. It proposes that the disease can enter an extended and insidious prodromal phase, with such nonspecific symptoms as fatigue, dizziness, headache, depression, and anxiety—often ignored or misdiagnosed. These could all be early whispers of MS in the making.

Led by Dr. Marta Ruiz-Algueró, a postdoctoral fellow at UBC, the study analyzed the medical histories of 2,038 Canadians with MS and compared them to more than 10,000 people without the condition. Using detailed administrative and clinical records that spanned 25 years, researchers tracked how often patients visited healthcare providers before their first classical MS symptoms.

15 years before diagnosis, people who later developed MS were already visiting general practitioners more frequently. Their complaints often centered on fatigue, pain, dizziness, headaches, and mental health concerns like anxiety and depression.

<strong>12 years before: Psychiatrist visits began to rise.</strong>

8 to 9 years before: Visits to neurologists and ophthalmologists increased, often due to vision issues or unexplained nerve-related symptoms.

3 to 5 years before: More visits to emergency medicine and radiology departments.

1 year before diagnosis: Healthcare use spiked across multiple specialties, especially neurology and emergency medicine.

“These patterns suggest that MS has a long and complex prodromal phase where something is happening beneath the surface but hasn’t yet declared itself as MS,” said Dr. Ruiz-Algueró.

<h2>Is Mental Health One of the First Clues?</h2>

One of the most striking revelations was the presence of mental health conditions, particularly anxiety and depression, in the earliest stages of the disease's progression. These symptoms were found to be significantly more common in people who eventually developed MS—often more than a decade before diagnosis.

“We’re only now starting to understand what these early warning signs are, with mental health-related issues appearing to be among the earliest indicators,” added Ruiz-Algueró.

However, the researchers are clear: not everyone with depression or fatigue has MS, and most people with such symptoms will never develop the condition. But in combination with other red flags and patterns, these findings could help doctors detect MS earlier.

<h2>Why These Findings Could Change How MS is Diagnosed?</h2>

Traditionally, MS diagnosis hinges on a demyelinating event, such as vision loss or difficulty walking. But this study shifts the focus further upstream, suggesting that the disease process starts silently, even while symptoms seem unrelated or mild.

Dr. Helen Tremlett, senior author of the study, emphasized that early detection is key:

“By identifying these earlier red flags, we may eventually be able to intervene sooner—whether that’s through monitoring, support, or preventive strategies.”

The implication is profound: if clinicians know what to look for, they could start identifying people at risk much earlier and possibly even slow the progression before major damage occurs.

Multiple sclerosis is an autoimmune condition where the immune system mistakenly attacks the protective covering of nerves—the myelin sheath. Over time, this leads to inflammation, scarring, and disruption in the brain’s ability to communicate with the rest of the body. Common symptoms include:

<ul><li>Chronic fatigue</li><li>Numbness or tingling</li><li>Loss of coordination or balance</li><li>Vision problems</li><li>Muscle weakness</li><li>Memory and cognitive changes</li></ul>

Despite decades of research, the exact cause of MS remains unknown. Genetics, viral infections, environmental factors, and immune system dysfunction are all believed to play roles. Previous studies have also identified MS-specific antibodies in blood up to five years before symptoms, suggesting the immune system may go rogue much earlier than expected.

This extended prodromal phase isn't unique to MS. Parkinson’s disease, for instance, has long been known to begin with subtle mood changes, constipation, and sleep disturbances years before motor symptoms appear.

Multiple sclerosis (MS) tends to be viewed as an abrupt disease—vision loss, numbness, tiredness, and other neurological interruptions. But based on a revolutionary new study at the University of British Columbia (UBC), the body could begin to send warning signals as much as 15 years before a diagnosis is officially made.This study, which appeared in JAMA Network Open, contradicts decades of premises on when MS really gets started. It proposes that the disease can enter an extended and insidious prodromal phase, with such nonspecific symptoms as fatigue, dizziness, headache, depression, and anxiety—often ignored or misdiagnosed. These could all be early whispers of MS in the making.Led by Dr. Marta Ruiz-Algueró, a postdoctoral fellow at UBC, the study analyzed the medical histories of 2,038 Canadians with MS and compared them to more than 10,000 people without the condition. Using detailed administrative and clinical records that spanned 25 years, researchers tracked how often patients visited healthcare providers before their first classical MS symptoms.15 years before diagnosis, people who later developed MS were already visiting general practitioners more frequently. Their complaints often centered on fatigue, pain, dizziness, headaches, and mental health concerns like anxiety and depression.12 years before: Psychiatrist visits began to rise.8 to 9 years before: Visits to neurologists and ophthalmologists increased, often due to vision issues or unexplained nerve-related symptoms.3 to 5 years before: More visits to emergency medicine and radiology departments.1 year before diagnosis: Healthcare use spiked across multiple specialties, especially neurology and emergency medicine.“These patterns suggest that MS has a long and complex prodromal phase where something is happening beneath the surface but hasn’t yet declared itself as MS,” said Dr. Ruiz-Algueró.Is Mental Health One of the First Clues?One of the most striking revelations was the presence of mental health conditions, particularly anxiety and depression, in the earliest stages of the disease's progression. These symptoms were found to be significantly more common in people who eventually developed MS—often more than a decade before diagnosis.“We’re only now starting to understand what these early warning signs are, with mental health-related issues appearing to be among the earliest indicators,” added Ruiz-Algueró.However, the researchers are clear: not everyone with depression or fatigue has MS, and most people with such symptoms will never develop the condition. But in combination with other red flags and patterns, these findings could help doctors detect MS earlier.Why These Findings Could Change How MS is Diagnosed?Traditionally, MS diagnosis hinges on a demyelinating event, such as vision loss or difficulty walking. But this study shifts the focus further upstream, suggesting that the disease process starts silently, even while symptoms seem unrelated or mild.Dr. Helen Tremlett, senior author of the study, emphasized that early detection is key:“By identifying these earlier red flags, we may eventually be able to intervene sooner—whether that’s through monitoring, support, or preventive strategies.”The implication is profound: if clinicians know what to look for, they could start identifying people at risk much earlier and possibly even slow the progression before major damage occurs.How MS Works?Multiple sclerosis is an autoimmune condition where the immune system mistakenly attacks the protective covering of nerves—the myelin sheath. Over time, this leads to inflammation, scarring, and disruption in the brain’s ability to communicate with the rest of the body. Common symptoms include:Chronic fatigueNumbness or tinglingLoss of coordination or balanceVision problemsMuscle weaknessMemory and cognitive changesDespite decades of research, the exact cause of MS remains unknown. Genetics, viral infections, environmental factors, and immune system dysfunction are all believed to play roles. Previous studies have also identified MS-specific antibodies in blood up to five years before symptoms, suggesting the immune system may go rogue much earlier than expected.This extended prodromal phase isn't unique to MS. Parkinson’s disease, for instance, has long been known to begin with subtle mood changes, constipation, and sleep disturbances years before motor symptoms appear.Tremlett and her team say MS is now showing similar patterns, and it’s time to recognize that the disease doesn’t start with the first lesion—it starts long before that.“This is the most comprehensive picture to date of how patients engage with a range of healthcare providers in the years leading up to a diagnosis,” said Tremlett. “Our findings dramatically shift the timeline for when these early warning signs are thought to begin.”While there's still no cure for MS, early detection could pave the way for better disease management, fewer relapses, and slower progression. If you're experiencing chronic fatigue, unexplained pain, dizziness, or persistent mental health concerns—and you’re not getting answers—it’s worth advocating for yourself. While these symptoms are common and non-specific, studies like this show they may sometimes be the earliest signs of something more serious, like MS.

Explained: An Overview Of How Vaccine Policies Have Changed Under RFK Jr

Quick Stories

US Schools Reopen: Here Is Your Guide To The Lifesaving Vaccines Every Child Should Have

No More BBL For Non-Medics, UK to Regulate High-Risk Beauty Procedures

Subtle Symptoms May Indicate To Early Warning Signs MS, 15 Years Before You Are Diagnosed

Health Conditions A-Z

US Schools Reopen: Here Is Your Guide To The Lifesaving Vaccines Every Child Should Have

Explained: An Overview Of How Vaccine Policies Have Changed Under RFK Jr

FDA Approves First Neuroimmune Modulation Device for Rheumatoid Arthritis